Effect of statins on the prevention of recurrent thrombosis in thrombotic antiphospholipid syndrome

Pregnancy and Venous Thromboembolism: Risk Factors, Trends, Management, and Mortality

(2020) Mohammed A. Alsheef et al.   Biomed Research International

16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends

(2020) Hannah Cohen et al.   LUPUS

EULAR recommendations for the management of antiphospholipid syndrome in adults

(2019) Maria G Tektonidou et al.   ANNALS OF THE RHEUMATIC DISEASES

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome

(2018) Vittorio Pengo et al.   BLOOD

Diagnosis and Management of the Antiphospholipid Syndrome

(2018) David Garcia et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and efficacy of statin therapy

(2018) Bhavin B. Adhyaru et al.   Nature Reviews Cardiology

Efficacy of dual antiplatelet therapy for preventing recurrence of arterial thrombosis in patients with antiphospholipid syndrome

(2018) Naoki Ohnishi et al.   RHEUMATOLOGY

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

(2017) Brian A. Ference et al.   EUROPEAN HEART JOURNAL

Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy

(2016) Eleftheria Lefkou et al.   JOURNAL OF CLINICAL INVESTIGATION

Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome

(2015) Cristina Belizna   AUTOIMMUNITY REVIEWS

Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients

(2014) R Cervera et al.   ANNALS OF THE RHEUMATIC DISEASES

A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients

(2013) Doruk Erkan et al.   ANNALS OF THE RHEUMATIC DISEASES

Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome

(2010) C. Lopez-Pedrera et al.   ANNALS OF THE RHEUMATIC DISEASES

Antiphospholipid syndrome

(2010) Guillermo Ruiz-Irastorza et al.   LANCET

Statins for the Treatment of Antiphospholipid Syndrome?

(2009) Praveen Jajoria et al.   Annals of the New York Academy of Sciences

Clinical course of high-risk patients diagnosed with antiphospholipid syndrome

(2009) V. PENGO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Effects of Statins on High-Density Lipoproteins: A Potential Contribution to Cardiovascular Benefit

(2008) Fergus McTaggart et al.   CARDIOVASCULAR DRUGS AND THERAPY

General Cardiovascular Risk Profile for Use in Primary Care

(2008) Ralph B. D’Agostino et al.   CIRCULATION